Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQESPERION THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESPR - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -433.51M | $ -104.02M | 0% |
| 3/31/2025 | $ -426.21M | $ -153.22M | 0% |
| 12/31/2024 | $ -388.72M | $ -51.74M | 0% |
| 9/30/2024 | $ -370.21M | $ -86.77M | 0% |
| 6/30/2024 | $ -344.22M | $ -98.5M | 0% |
| 3/31/2024 | $ -294.3M | $ -86.51M | 0% |
| 12/31/2023 | $ -454.99M | $ -209.25M | 0% |
| 9/30/2023 | $ -410M | $ -208.39M | 0% |
| 6/30/2023 | $ -371.98M | $ -222.26M | 0% |
| 3/31/2023 | $ -329.66M | $ -238.65M | 0% |
Key Performance Insights, Last 5 Years
- ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -1127.47%.
- Over the past 5 years, ESPERION THERAPEUTICS INC's average ROE has been -1127.47%.
- The median ROE for ESPERION THERAPEUTICS INC during this period was -1127.47%
- ESPERION THERAPEUTICS INC reached its highest ROE over the past 5 years at -1127.47%.
- The lowest ROE recorded by ESPERION THERAPEUTICS INC in the same timeframe -1127.47%
ESPERION THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ESPERION THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -101.02M ] / Equity [ $ 8.96M ]
(=) ROE [ -1127.47% ] ESPR - Return on Equity, Last 5 years
-1127.47%
Minimum
Sep 30, 2020
-1127.47%
Maximum
Sep 30, 2020
-1127.47%
Average
-1127.47%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |